Last reviewed · How we verify
Restylane Volyme
At a glance
| Generic name | Restylane Volyme |
|---|---|
| Sponsor | Chongqing Jinsaixing Medical Technology Co., Ltd |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- The Correction of Midface Volume Deficiency and/or Midface Contour Deficiency (NA)
- Evaluate the Effectiveness and Safety of Restylane Volyme in the Treatment of Temple Hollowing (NA)
- Study to Evaluate Satisfaction After Treatment With Restylane (NA)
- Restylane Volyme for Correction of Midface Volume Deficit and/or Midface Contour Deficiency (NA)
- A Study to Evaluate Effectiveness and Safety of Hyaluronic Acid (HA) Fillers (NA)
- Midfacial Product Selection (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Restylane Volyme CI brief — competitive landscape report
- Restylane Volyme updates RSS · CI watch RSS
- Chongqing Jinsaixing Medical Technology Co., Ltd portfolio CI